
Beyfortus Shows Strong RSV Protection in Infants
Beyfortus (nirservimab) offered strong protection against respiratory syncytial virus (RSV)-related outcomes in infants and young children, according to a recent study published in JAMA Network. RSV is a leading cause of lower respiratory tract infections …